Rock Springs Capital Management LP Bolt Biotherapeutics, Inc. Transaction History

Rock Springs Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.19 - $13.97 $6.91 Million - $23 Million	-1,649,248 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.15 - $18.6 $334,500 - $558,000	30,000 Added 1.85%	1,649,248 $20.9 Million
Q2 2021 Aug 16, 2021	BUY	$15.4 - $31.46 $924,000 - $1.89 Million	60,000 Added 3.85%	1,619,248 $25 Million
Q1 2021 May 17, 2021	BUY	$25.86 - $39.93 $40.3 Million - $62.3 Million	1,559,248 New	1,559,248 $51.3 Million

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.